M
MaximBio
A dedicated company to the development of high quality, in-vitro diagnostic (IVD) and Point-of-Care (POC) testing solutions that positively impact public health
About MaximBio
Maxim Biomedical, accessible via maximbio.com, is a prominent player in the field of in vitro diagnostics (IVD) and medical device manufacturing. The company operates in both private and government sectors, focusing on the development and production of high-quality diagnostic tests and medical devices. Their expertise spans across Class I, Class II, and Class III medical devices, which vary in complexity and regulatory requirements.
Maxim Biomedical serves a diverse clientele, including healthcare providers, research institutions, and government agencies. Their primary market is the healthcare industry, where they contribute significantly to public health through innovative diagnostic solutions. The company’s business model revolves around both the development of their own line of diagnostic tests and partnering with other organizations to bring new assays (tests) from concept to market.
Revenue generation for Maxim Biomedical comes from the sale of their proprietary diagnostic tests and from contract manufacturing services. By offering custom manufacturing solutions, they cater to specific client needs, ensuring high standards of quality and compliance with industry regulations. This dual approach not only diversifies their income streams but also positions them as a versatile and reliable partner in the medical device industry.
Maxim Biomedical's commitment to exceeding customer expectations is evident in their dedication to innovation and excellence. Their team of experts works tirelessly to advance healthcare by providing reliable and effective diagnostic tools. This focus on quality and customer success has established them as a trusted name in the field of medical diagnostics.
Source: Dealroom company dataAt a glance
- Founded
- 2005
- Headquarters
- Rockville, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
European Innovation Council
US Department of Health and Human Services
National Institutes of Health
Series B and later1 investor entered at this stage
- CICTM Investments
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MaximBio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MaximBio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.